ZA99874B - Organic compounds. - Google Patents

Organic compounds.

Info

Publication number
ZA99874B
ZA99874B ZA9900874A ZA99874A ZA99874B ZA 99874 B ZA99874 B ZA 99874B ZA 9900874 A ZA9900874 A ZA 9900874A ZA 99874 A ZA99874 A ZA 99874A ZA 99874 B ZA99874 B ZA 99874B
Authority
ZA
South Africa
Prior art keywords
organic compounds
epothilone
administration
methods
pharmaceutical formulations
Prior art date
Application number
ZA9900874A
Other languages
English (en)
Inventor
Peter Van Hoogevest
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10826504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA99874(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA99874B publication Critical patent/ZA99874B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9900874A 1998-02-05 1999-02-04 Organic compounds. ZA99874B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9802451.6A GB9802451D0 (en) 1998-02-05 1998-02-05 Organic compounds

Publications (1)

Publication Number Publication Date
ZA99874B true ZA99874B (en) 1999-08-05

Family

ID=10826504

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900874A ZA99874B (en) 1998-02-05 1999-02-04 Organic compounds.

Country Status (9)

Country Link
EP (1) EP1800664B8 (da)
AT (1) ATE427736T1 (da)
CY (1) CY1109190T1 (da)
DE (1) DE69940708D1 (da)
DK (1) DK1800664T3 (da)
ES (1) ES2324376T3 (da)
GB (1) GB9802451D0 (da)
PT (1) PT1800664E (da)
ZA (1) ZA99874B (da)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
JP4183099B2 (ja) * 1995-11-17 2008-11-19 ゲゼルシャフト・フュア・ビオテヒノロジッシェ・フォルシュング・ミット・ベシュレンクテル・ハフツング(ゲー・ベー・エフ) エポチロンcおよびd、製造法ならびに組成物
CN1304058C (zh) * 1996-03-12 2007-03-14 Pg-Txl有限公司 水溶性紫杉醇产品
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
TR200002299T2 (tr) * 1998-02-05 2000-11-21 Novartis Ag Epotilon kompozisyonları.

Also Published As

Publication number Publication date
CY1109190T1 (el) 2014-07-02
ATE427736T1 (de) 2009-04-15
EP1800664B1 (en) 2009-04-08
DE69940708D1 (de) 2009-05-20
EP1800664B8 (en) 2010-12-15
GB9802451D0 (en) 1998-04-01
DK1800664T3 (da) 2009-07-20
ES2324376T3 (es) 2009-08-05
PT1800664E (pt) 2009-07-10
EP1800664A1 (en) 2007-06-27

Similar Documents

Publication Publication Date Title
MY125921A (en) Compositions containing organic compounds
NZ513629A (en) C-21 modified epothilones
WO2000007979A3 (en) Compounds and compositions for delivering active agents
GEP20053473B (en) High Potency Dihydroergotamine Compositions
TW355683B (en) Composition containing micronized nebivolol
EP1093819A3 (en) Compounds and compositions for delivering active agents
IL231675A0 (en) Concentrated protein compositions with reduced viscosity
AU2001241423A1 (en) Needleless syringe
CA2338358A1 (en) Compounds and compositions for delivering active agents
AU2001237485A1 (en) Needleless syringe with two injection speed levels
GEP20043203B (en) EP4 Receptor Selective Agonists in the Treatment of Osteoporosis
IL136512A0 (en) Intravenous infusion administration set
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
NZ508249A (en) Use of PEG-IFN-alpha conjugates in association with ribavirin for the treatment of chronic hepatitis C
AU2002236647A1 (en) Method and device for administering medication and/or placebo
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
EP1105102B8 (fr) Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine
WO2000003724A1 (en) Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
AU2001294240A1 (en) 2,2-diphenylbutanamide derivatives and medicines containing the same
GB9802451D0 (en) Organic compounds
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
IL139863A0 (en) 3,4-diphenyl bicyclo [4.3.0] nonyl derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
AU3076600A (en) 3,7-disubstituted indole derivatives and medicinal compositions containing the same
WO2001022917A8 (en) Effervescent compositions comprising nimesulide